OVIS™ CD19 CAR-T cell therapy targeting DLBCL
(Code named: CRC01)
Jong Ran Kim
Head of Clinical Development Center
Executive Vice President
Hyeun Jin Seo
Mi Kyung Kim, Ph.D.
Managing Director of Clinical Project Management
Changwan Hong, Ph.D.
Associate professor, Department of Anatomy, PNU School of Medicine
Clinical development Advisor
Law office Cheongdang Partner Attorney
Jin Kyong Park
Chief Financial Officer
CFO / Director
Hyun-Bo Sim, Ph.D.
Ewha Womans University Associate Professor of department of Bioinspired Science
Hyeong Cheol Kim, Ph.D
Head of R&D Center
Chanhyuk Kim, Ph.D.
KAIST Assistant Professor of Department of Life Sciences
Jung Hee Lim
Intervest Executive Director
Head of production Engneering Center